Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1755-8794
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma ; volume:13 ; number:1 ; day:10 ; month:11 ; year:2020 ; pages:1-11 ; date:12.2020
BMC medical genomics ; 13, Heft 1 (10.11.2020), 1-11, 12.2020

Urheber
Lee, Eunjin
Lee, Ji Won
Lee, Boram
Park, Kyunghee
Shim, Joonho
Yoo, Keon Hee
Koo, Hong Hoe
Sung, Ki Woong
Park, Woong-Yang
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s12920-020-00819-5
URN
urn:nbn:de:101:1-2020122121170837203865
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:24 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Lee, Eunjin
  • Lee, Ji Won
  • Lee, Boram
  • Park, Kyunghee
  • Shim, Joonho
  • Yoo, Keon Hee
  • Koo, Hong Hoe
  • Sung, Ki Woong
  • Park, Woong-Yang
  • SpringerLink (Online service)

Ähnliche Objekte (12)

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma

Aurora-A prevents transcription-replication conflicts in MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

Impact of extracellular matrix stiffness on genomic heterogeneity in MYCN-amplified neuroblastoma cell line

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma

Age related gene DST represents an independent prognostic factor for MYCN non-amplified neuroblastoma

MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma

Hochschulschrift

MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma

MYCN, proliferative heterogeneity and treatment response in neuroblastoma

Hochschulschrift

MYCN, proliferative heterogeneity and treatment response in neuroblastoma

Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma

Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma

Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma

Identification and validation of a novel five-gene signature in high-risk MYCN-not-amplified neuroblastoma

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells

Verbundene Objekte